Previous close | 20.40 |
Open | 20.40 |
Bid | 0.00 |
Ask | 0.00 |
Strike | 80.00 |
Expiry date | 2025-01-17 |
Day's range | 20.40 - 20.40 |
Contract range | N/A |
Volume | |
Open interest | 1.94k |
IRVINE, Calif., April 18, 2024--Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
Strength in Molecular Diagnostics business and GYN Surgical is likely to have driven Hologic's (HOLX) fiscal second-quarter performance.
The strong adoption of transcatheter heart valves is expected to have led to Edwards Lifesciences' (EW) growth in the first quarter.